World Blood Cancer Day 2021

28th May 2021


On World Blood Cancer Day 2021 we are highlighting the global impact of the national Trials Acceleration Programme (TAP) which is solely funded by Cure Leukaemia.

Professor Charlie Craddock CBE explains why this network is so vital:


Dr Steve Knapper from University of Wales, Cardiff discusses the potential global impact of the VICTOR trial for acute myeloid leukaemia patients which is now open in the UK:

 

Blood cancer survivor Nigel Wheatley discusses his treatment on a clinical trial delivered by our TAP-funded centre at University College Hospital London NHS Foundation Trust. Click HERE for the full story

General Director of The Tour de France, Christian Prudhomme, explains why they are proud to be partnering with Cure Leukaemia in the UK:

 

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell